Literature DB >> 28260188

Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS).

Paolo Tini1,2,3, Valerio Nardone4,5, Pierpaolo Pastina4,5, Giuseppe Battaglia4,5, Claudia Vinciguerra6, Tommaso Carfagno4,7, Giovanni Rubino4,7, Salvatore Francesco Carbone4,8, Lucio Sebaste4,7, Alfonso Cerase9, Antonio Federico6, Luigi Pirtoli4,7,5.   

Abstract

Radiosurgery (SRS) is widely used in the treatment of brain oligo-metastases from NSCLC. The aim of present study is to evaluate the extent of perilesional edema in brain metastases as predictive factor of treatment response. This single center retrospective study included 42 consecutive patients (January 2011-December 2014) with 1-2 brain metastasis from NSCLC treated with Radiosurgery (SRS). Extent of perilesional edema was measured as maximal extension from the edge of lesion and classified as minor (<10 mm) or major (≥10 mm). We analyzed Modality of Brain Recurrence (MBR), classified as in-field or out-of- field, and Brain Progression Free-Survival (BPFS) after treatment stratified according to extent of perilesional edema. Analyzing modality of brain recurrence and BPFS, after a median follow-up of 6 months, we found that patients with minor edema had a better radiological response to SRS with none in-field recurrences and a lower risk of the onset of new brain lesions (out-of-field recurrence). Instead, patients group with major edema had a worse response rate of lesions treated, further, a higher risk of out-of-field brain relapse. Extent of perilesional edema in brain metastasis from NSCLC could be a predictive factor of response and brain progression after SRS treatment alone.

Entities:  

Keywords:  Brain metastases; NSCLC; Peritumoral edema; Predictor; Stereotactic radiosurgery

Mesh:

Year:  2017        PMID: 28260188     DOI: 10.1007/s10072-017-2876-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  30 in total

Review 1.  The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.

Authors:  Minesh P Mehta; May N Tsao; Timothy J Whelan; David E Morris; James A Hayman; John C Flickinger; Michael Mills; C Leland Rogers; Luis Souhami
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-09-01       Impact factor: 7.038

2.  Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone.

Authors:  Hidefumi Aoyama; Masao Tago; Norio Kato; Tatsuya Toyoda; Masahiro Kenjyo; Saeko Hirota; Hiroki Shioura; Taisuke Inomata; Etsuo Kunieda; Kazushige Hayakawa; Keiichi Nakagawa; Gen Kobashi; Hiroki Shirato
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-08-01       Impact factor: 7.038

3.  Statistical analysis of multi-b factor diffusion weighted images can help distinguish between vasogenic and tumor-infiltrated edema.

Authors:  Christophe Vandendries; Denis Ducreux; Catherine Lacroix; Béatrice Ducot; Guillaume Saliou
Journal:  J Magn Reson Imaging       Date:  2013-11-04       Impact factor: 4.813

4.  Safety and efficacy of Gamma Knife surgery for brain metastases in eloquent locations.

Authors:  Nicolas Dea; Martin Borduas; Brendan Kenny; David Fortin; David Mathieu
Journal:  J Neurosurg       Date:  2010-12       Impact factor: 5.115

Review 5.  Building immunity to cancer with radiation therapy.

Authors:  Suresh J Haikerwal; Jim Hagekyriakou; Michael MacManus; Olga A Martin; Nicole M Haynes
Journal:  Cancer Lett       Date:  2015-01-12       Impact factor: 8.679

6.  A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320.

Authors:  Paul W Sperduto; Meihua Wang; H Ian Robins; Michael C Schell; Maria Werner-Wasik; Ritsuko Komaki; Luis Souhami; Mark K Buyyounouski; Deepak Khuntia; William Demas; Sunjay A Shah; Lucien A Nedzi; Gad Perry; John H Suh; Minesh P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-02-04       Impact factor: 7.038

7.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Authors:  Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers
Journal:  Lancet Oncol       Date:  2009-10-02       Impact factor: 41.316

8.  Perfusion-weighted imaging of peritumoral edema can aid in the differential diagnosis of glioblastoma mulltiforme versus brain metastasis.

Authors:  Osnat Halshtok Neiman; Siegal Sadetzki; Angela Chetrit; Stephen Raskin; Gal Yaniv; Chen Hoffmann
Journal:  Isr Med Assoc J       Date:  2013-02       Impact factor: 0.892

Review 9.  Role of stereotactic radiosurgery in patients with more than four brain metastases.

Authors:  Vikram Jairam; Veronica L S Chiang; James B Yu; Jonathan P S Knisely
Journal:  CNS Oncol       Date:  2013-03

Review 10.  The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline.

Authors:  Timothy C Ryken; Michael McDermott; Paula D Robinson; Mario Ammirati; David W Andrews; Anthony L Asher; Stuart H Burri; Charles S Cobbs; Laurie E Gaspar; Douglas Kondziolka; Mark E Linskey; Jay S Loeffler; Minesh P Mehta; Tom Mikkelsen; Jeffrey J Olson; Nina A Paleologos; Roy A Patchell; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2009-12-03       Impact factor: 4.130

View more
  8 in total

1.  Role of perilesional edema and tumor volume in the prognosis of non-small cell lung cancer (NSCLC) undergoing radiosurgery (SRS) for brain metastases.

Authors:  Valerio Nardone; Sara Nanni; Pierpaolo Pastina; Claudia Vinciguerra; Alfonso Cerase; Pierpaolo Correale; Cesare Guida; Antonio Giordano; Paolo Tini; Alfonso Reginelli; Salvatore Cappabianca; Luigi Pirtoli
Journal:  Strahlenther Onkol       Date:  2019-05-23       Impact factor: 3.621

2.  News on the journal Neurological Sciences in 2017.

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2018-01       Impact factor: 3.307

Review 3.  Machine Learning-Based Radiomics in Neuro-Oncology.

Authors:  Felix Ehret; David Kaul; Hans Clusmann; Daniel Delev; Julius M Kernbach
Journal:  Acta Neurochir Suppl       Date:  2022

4.  En Bloc Resection of Solitary Brain Metastasis: The Role of Perilesional Edema.

Authors:  Placido Bruzzaniti; Pierfrancesco Lapolla; Antonio Santoro; Pietro Familiari; Alessia D'Amico; Giuseppa Zancana; Michael Katsev; Michela Relucenti; Giuseppe Familiari; Andrea Mingoli; Giancarlo D'Andrea; Alessandro Frati; Maurizio Salvati
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

5.  Perilesional edema in brain metastases as predictive factor of response to systemic therapy in non-small cell lung cancer patients: a preliminary study.

Authors:  Montse Alemany; Marta Domènech; Andreas A Argyriou; Noelia Vilariño; Carles Majós; Pablo Naval-Baudin; Anna Lucas; Ramón Palmero; Marta Simó; Ernest Nadal; Jordi Bruna
Journal:  Ann Transl Med       Date:  2021-04

6.  Radiographic Features of Metastatic Brain Tumors from ALK-rearranged Non-small Cell Lung Cancer: Implications for Optimal Treatment Modalities.

Authors:  Li Chu; Jianjiao Ni; Xi Yang; Tong Tong; Jialei Wang; Fang Yin; Ruimin Li; Yida Li; Liqing Zou; Yuan Li; Congying Xie; Guodong Li; Zhengfei Zhu
Journal:  J Cancer       Date:  2019-10-22       Impact factor: 4.207

7.  Radiomic analysis of magnetic resonance imaging predicts brain metastases velocity and clinical outcome after upfront radiosurgery.

Authors:  Che-Yu Hsu; Furen Xiao; Kao-Lang Liu; Ting-Li Chen; Yueh-Chou Lee; Weichung Wang
Journal:  Neurooncol Adv       Date:  2020-08-25

Review 8.  Applications of radiomics and machine learning for radiotherapy of malignant brain tumors.

Authors:  Martin Kocher; Maximilian I Ruge; Norbert Galldiks; Philipp Lohmann
Journal:  Strahlenther Onkol       Date:  2020-05-11       Impact factor: 4.033

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.